CDT Equity Inc. (CDT) Corporate Subsidiaries
CDT Equity Inc. (CDT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CDT
CIK: 1896212
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJin Dong
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-16 | 2026-10-16 | PRE 14A | 0001493152-26-047422 | View SEC Doc Filr Page |
| 424B3 | 2026-10-13 | — | 424B3 | 0001493152-26-046739 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-06 | 8-K | 0001493152-26-046738 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-08 | — | SCHEDULE 13G/A Filing | 0001753926-26-001917 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001753926-26-001911 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001753926-26-001910 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001753926-26-001909 | View SEC Doc Filr Page |
| 424B3 | 2026-10-02 | — | 424B3 | 0001493152-26-045443 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-24 | 8-K | 0001493152-26-044248 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | 424B3 | 0001493152-26-043404 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-14 | 8-K | 0001493152-26-043398 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | 424B3 | 0001493152-26-043361 | View SEC Doc Filr Page |
| EFFECT | 2026-09-17 | — | EFFECT Filing | 9999999995-26-003001 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-09 | — | SCHEDULE 13G Filing | 0001753926-26-001737 | View SEC Doc Filr Page |
| S-1 | 2026-09-08 | — | S-1 | 0001493152-26-041808 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-08-31 | 8-K | 0001493152-26-041533 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-02 | — | SCHEDULE 13G Filing | 0001753926-26-001700 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-07-30 | 4 Filing | 0001753926-26-001698 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-02 | — | SCHEDULE 13D/A Filing | 0001753926-26-001696 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-28 | 8-K | 0001493152-26-041016 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-28 | 8-K | 0001493152-26-040929 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-21 | — | SCHEDULE 13G Filing | 0001753926-26-001589 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-21 | — | SCHEDULE 13G Filing | 0001753926-26-001588 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-21 | 2026-07-30 | 8-K/A | 0001493152-26-039588 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-21 | 2026-02-19 | 8-K/A | 0001493152-26-039587 | View SEC Doc Filr Page |